| BID | 19.70 | ASK | 19.74 | ||
| Open | 20.00 | Previous Close | 20.16 | ||
| Pre-Market | - | After-Market | - | ||
| - -% | - - |
| Target Price | 23.50 | Analyst Rating | Strong Buy 1.44 | |
| Potential % | 19.23 | Finscreener Ranking | ★★★★ 55.47 | |
| Insiders Trans % 3/6/12 mo. | -/-/-100 | Value Ranking | ★★ 47.80 | |
| Insiders Value % 3/6/12 mo. | -/-/-100 | Growth Ranking | ★★ 44.64 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/-100 | Income Ranking | — - | |
| Market Cap | 1.70B | Earnings Rating | Strong Buy | |
| Price Range Ratio 52W % | 84.71 | Earnings Date | 6th May 2021 |
Today's Price Range 19.6120.22 | 52W Range 5.2222.35 | 5 Year PE Ratio Range -12.803.30 |
Summary:
Buy
| Technical Indicators: | Buy |
| Moving Averages: | Buy |
| Performance | |||
|---|---|---|---|
| 1 Week | -0.20% | ||
| 1 Month | -5.00% | ||
| 3 Months | 14.09% | ||
| 6 Months | 77.93% | ||
| 1 Year | 219.74% | ||
| 3 Years | 22.18% | ||
| 5 Years | 81.29% | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -20.39 | |||
ROE last 12 Months | -41.17 | |||
ROA (5Y Avg) | -12.88 | |||
ROA last 12 Months | -22.27 | |||
ROC (5Y Avg) | -15.89 | |||
ROC last 12 Months | -41.58 | |||
Return on invested Capital Q | -0.68 | |||
Return on invested Capital Y | -27.25 | |||
Assets Turnover | 0.50 | |||
Receivables Turnover | 7.10 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -5.30 | ||||
| 2.80 | ||||
| 2.24 | ||||
| 170.30 | ||||
| -45.60 | ||||
| -0.19 | ||||
| -541.09 | ||||
| 7.20 | ||||
| 1.75B | ||||
| Forward PE | -144.28 | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.20 | ||||
| 1.40 | ||||
| 0.34 | ||||
| 0.58 | ||||
| -10.90 | ||||
| Leverage Ratio | 2.10 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 31.40 | ||||
| -52.80 | ||||
| -46.40 | ||||
| -38.30 | ||||
| -33.00 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 775.15M | ||||
| 9.00 | ||||
| 30.23 | ||||
| 47.89 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q04 2020 | -0.10 | -0.06 | 40.00 |
| Q03 2020 | -0.13 | -0.07 | 46.15 |
| Q02 2020 | -0.17 | -0.07 | 58.82 |
| Q01 2020 | -0.20 | -0.19 | 5.00 |
| Q04 2019 | -0.10 | -0.08 | 20.00 |
| Q03 2019 | -0.21 | -0.16 | 23.81 |
| Q02 2019 | -0.29 | -0.31 | -6.90 |
| Q01 2019 | -0.40 | -0.38 | 5.00 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 3/2021 QR | -0.10 | 37.50 | Positive |
| 6/2021 QR | -0.08 | 33.33 | Positive |
| 12/2021 FY | -0.36 | 20.00 | Positive |
| 12/2022 FY | -0.14 | 36.36 | Positive |
| Next Report Date | 6th May 2021 |
| Estimated EPS Next Report | -0.10 |
| Estimates Count | 3 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 203.87K |
| Shares Outstanding | 86.09M |
| Trades Count | 2.50K |
| Dollar Volume | 21.01M |
| Avg. Volume | 570.03K |
| Avg. Weekly Volume | 337.27K |
| Avg. Monthly Volume | 499.04K |
| Avg. Quarterly Volume | 575.95K |
Evolent Health Inc Class A (NYSE: EVH) stock closed at 20.16 per share at the end of the most recent trading day (a -2.23% change compared to the prior day closing price) with a volume of 273.95K shares and market capitalization of 1.70B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 2900 people. Evolent Health Inc Class A CEO is Seth Blackley.
The one-year performance of Evolent Health Inc Class A stock is 219.74%, while year-to-date (YTD) performance is 25.76%. EVH stock has a five-year performance of 81.29%. Its 52-week range is between 5.22 and 22.35, which gives EVH stock a 52-week price range ratio of 84.71%
Evolent Health Inc Class A currently has a PE ratio of -5.30, a price-to-book (PB) ratio of 2.80, a price-to-sale (PS) ratio of 2.24, a price to cashflow ratio of 170.30, a PEG ratio of 2.32, a ROA of -22.27%, a ROC of -41.58% and a ROE of -41.17%. The company’s profit margin is -33.00%, its EBITDA margin is -46.40%, and its revenue ttm is $775.15 Million , which makes it $9.00 revenue per share.
Of the last four earnings reports from Evolent Health Inc Class A, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Evolent Health Inc Class A’s next earnings report date is 06th May 2021.
The consensus rating of Wall Street analysts for Evolent Health Inc Class A is Strong Buy (1.44), with a target price of $23.5, which is +19.23% compared to the current price. The earnings rating for Evolent Health Inc Class A stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Evolent Health Inc Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Evolent Health Inc Class A has a Buy technical analysis rating based on Technical Indicators (ADX : 12.35, ATR14 : 0.98, CCI20 : 27.16, Chaikin Money Flow : -0.10, MACD : 0.38, Money Flow Index : 68.51, ROC : 0.80, RSI : 48.30, STOCH (14,3) : 46.69, STOCH RSI : 0.20, UO : 51.64, Williams %R : -53.31), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Evolent Health Inc Class A in the last 12-months were: Jonathan D. Weinberg (Sold 0 shares of value $-38 400 ), Jonathan D. Weinberg (Sold 10 000 shares of value $130 100 )
Evolent Health Inc Class A
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's reportable segments are Service segment which includes value-based care services, specialty care management services and comprehensive health plan administration services. and True Health segment consists of a commercial health plan it operates in New Mexico that focuses on small and large businesses. It generates a majority of its revenue from the Service segment.
CEO: Seth Blackley
Telephone: +1 571 389-6000
Address: 800 N. Glebe Road, Arlington 22203, VA, US
Number of employees: 2 900
